Filing Flows › Envoy Medical (COCH) › Q3 2026 › vs Q3 2025
Envoy Medical (COCH) Q3 2026 vs Q3 2025 (year over year)
Envoy Medical's revenue rose $24K (+57%) from $42K in Q3 2025 to $66K in Q3 2026.
Envoy Medical, Q3 2026: revenue $66K (+57% year over year), net loss $3.9M, operating cash flow −$5.0M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $66K | $42K | $24K | +57% |
| Other income, net | $1.6M | −$1.2M | $2.8M | — |
| Net loss | $3.9M | $6.5M | −$2.5M | -39% |
| Costs & expenses | $5.6M | $6.5M | −$921K | -14% |
| Operating costs | $5.6M | $5.3M | $296K | +6% |
| Cost of revenue | $244K | $203K | $41K | +20% |
| Research & development | $3.1M | $2.7M | $377K | +14% |
| Sales & marketing | $157K | $405K | −$248K | -61% |
| General & admin | $2.1M | $2.0M | $126K | +6% |
| Operating cash sources | $5.4M | $4.6M | $833K | +18% |
| Depreciation | $75K | $76K | −$1K | -1% |
| Share-based compensation | $307K | $172K | $135K | +78% |
| Cash used in operations | $5.0M | $4.3M | $699K | +16% |
| Net loss absorbed | $3.9M | $6.5M | −$2.5M | -39% |
| Working capital & other | $1.5M | −$1.9M | $3.4M | — |
Questions
How much did Envoy Medical's revenue grow year over year in Q3 2026?
Envoy Medical's revenue rose $24K (+57%) from $42K in Q3 2025 to $66K in Q3 2026.